Innoviva (INVA) EBIAT (2016 - 2025)
Historic EBIAT for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $89.9 million.
- Innoviva's EBIAT rose 731203.63% to $89.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.6 million, marking a year-over-year increase of 75295.76%. This contributed to the annual value of $23.4 million for FY2024, which is 8698.43% down from last year.
- Innoviva's EBIAT amounted to $89.9 million in Q3 2025, which was up 731203.63% from $63.7 million recorded in Q2 2025.
- Innoviva's 5-year EBIAT high stood at $229.3 million for Q3 2022, and its period low was -$46.6 million during Q1 2025.
- Over the past 5 years, Innoviva's median EBIAT value was $34.9 million (recorded in 2023), while the average stood at $42.4 million.
- As far as peak fluctuations go, Innoviva's EBIAT tumbled by 280976.56% in 2024, and later surged by 731203.63% in 2025.
- Over the past 5 years, Innoviva's EBIAT (Quarter) stood at -$6.0 million in 2021, then plummeted by 70.56% to -$10.3 million in 2022, then crashed by 92.43% to -$19.8 million in 2023, then soared by 113.1% to $2.6 million in 2024, then surged by 3358.0% to $89.9 million in 2025.
- Its EBIAT stands at $89.9 million for Q3 2025, versus $63.7 million for Q2 2025 and -$46.6 million for Q1 2025.